Effects of Selective α 1 - and α 2 -Adrenergic Blockade on Coronary Flow Reserve After Coronary Stenting
- 3 December 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (23) , 2901-2907
Abstract
Background— Coronary flow reserve (CFR) is not normalized shortly after coronary stenting. We hypothesized that α-adrenergic coronary vasoconstriction acts to limit CFR. Methods and Results— We assessed flow velocity by Doppler wires and cross-sectional area by angiography in 46 patients undergoing coronary culprit lesion stenting (81±4% stenosis). Hyperemia was induced by adenosine (24 μg IC or 140 μg/kg per minute IV) before and after stenting. Finally, either the α 1 -antagonist urapidil (10 mg IC) or the α 2 -antagonist yohimbine (3 mg IC) was randomly combined with adenosine. In 8 subjects with angiographically normal coronary arteries, CFR was increased from 3.21±0.30 to 3.74±0.43 by yohimbine and to 4.58±0.65 by urapidil, respectively ( P =0.0001). Patients were divided according to the cutoff of CFR ≥3.0 (n=18) or 3.0 and Conclusions— Urapidil and yohimbine attenuated the CFR impairment occurring after revascularization by increasing both the epicardial vasodilator effect of adenosine and the blood flow velocity, thus suggesting that the adrenergic system plays an important role in limiting the capacity of the coronary circulation to dilate.Keywords
This publication has 15 references indexed in Scilit:
- Coronary microembolizationJACC, 2000
- Coronary-Artery Stenting Compared with Balloon Angioplasty for Restenosis after Initial Balloon AngioplastyNew England Journal of Medicine, 1998
- Postischemic Left Ventricular Dysfunction Is Abolished by Alpha-Adrenergic Blocking Agents 11This study was supported by institutional funds from the University of Milan (MURST 60%). Hewlett Packard Germany provided the echocardiographic equipment used in this study; Hewlett Packard Italiana S.P.A. provided technologic assistance in the acquisition of the data presented here.JACC, 1998
- The Alpha-1 Adrenergic Blocking Agent Urapidil Counteracts Postrotational Atherectomy “Elastic Recoil” Where Nitrates Have FailedThe American Journal of Cardiology, 1997
- Intravenous adenosine: Continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery diseaseJACC, 1991
- Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteriesThe Lancet, 1990
- Alpha 1-adrenoceptor activity regulates release of adenosine from the ischemic myocardium in dogs.Circulation Research, 1987
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: feed-back aggravation of myocardial ischemiaJournal of the Autonomic Nervous System, 1985
- α1 and α2-Adrenoceptor-Mediated Vasoconstriction of Large and Small Canine Coronary Arteries In VivoJournal of Cardiovascular Pharmacology, 1984